Showing results (101-110 of 1,055) with videos related to
Sort By:
Pageof 106
Hepatology International|April 6, 2023
Endoscopic band ligation is safe despite low platelet count and high INRNikolaus Pfisterer, Michael Schwarz, Mathias Jachs, et al.Journal of Hepatology|May 7, 2022
Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLDNina Bastati, Lucian Beer, Ahmed Ba-Ssalamah, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2020
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal HypertensionKatharina Wöran, Georg Semmler, Mathias Jachs, et al.JHEP Reports : Innovation in Hepatology|December 3, 2024
Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individualsGeorg Semmler, Oleksandr Petrenko, Juanjo Jose Lozano, et al.Plos One|April 7, 2023
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patientsLorenz Balcar, David Bauer, Katharina Pomej, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 15, 2021
PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary centerLorenz Balcar, Georg Semmler, Hannes Oberkofler, et al.Open Heart|March 12, 2026
Association of Life's Simple 7 with metabolic-associated steatotic liver disease and non-invasive fibrosis markersHannah Hofer, Sarah Wernly, Georg Semmler, et al.Wiener Klinische Wochenschrift|April 13, 2013
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II)Markus Peck-Radosavljevic, Bernhard Angermayr, Christian Datz, et al.Wiener Klinische Wochenschrift|June 26, 2023
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)Mattias Mandorfer, Elmar Aigner, Manfred Cejna, et al.Journal of Personalized Medicine|April 3, 2021
PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary CenterGeorg Semmler, Lorenz Balcar, Hannes Oberkofler, et al.Pageof 106